End­points News ranks the top 57 play­ers in the Covid-19 vac­cine race. Here's how it stacks up to­day

(This piece was last up­dat­ed on Oc­to­ber 29. End­points News will con­tin­ue to track the lat­est de­vel­op­ments through the FDA’s mar­ket­ing de­ci­sions.)

The 57 top play­ers now in or close to the clin­i­cal race to get a Covid-19 vac­cine over the fin­ish line are an­gling for a piece of a multi­bil­lion-dol­lar mar­ket. And be­ing among the lead­ers now be­hind Pfiz­er/BioN­Tech and Mod­er­na will play a big role in de­ter­min­ing just how big a piece.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER